In ZINC since | Heavy atoms | Benign functionality |
---|---|---|
October 11th, 2004 | 21 | Yes |
1-(tert-Butyl)-3-(p-tolyl)-1H-pyrazolo[3,4-d]pyrimidin-4-amine
Type pH range | xlogP | Des A‑Pol Apolar desolvation (kcal/mol) | Des Pol Polar desolvation (kcal/mol) | H Don H-bond donors | H Acc H-bond acceptors | Chg Net charge | tPSA (Ų) | MWT Molecular weight (g/mol) | RB Rotatable bonds | DL |
---|---|---|---|---|---|---|---|---|---|---|
Ref Reference (pH 7) | 3.00 | 8.7 | -8.34 | 2 | 5 | 0 | 70 | 281.363 | 2 | ↓ |
Note Type | Comments | Provided By |
---|---|---|
ALOGPS_SOLUBILITY | 9.53e-02 g/l | DrugBank-experimental |
Target | Src | Selleck Chemicals |
Indications | Src family tyrosine kinase inhibitor | KeyOrganics Bioactives |
PUBCHEM_PATENT_ID | WO2000042042A2 | IBM Patent Data |
Code | Description | Organism Class | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
CSK-1-E | Tyrosine-protein Kinase CSK (cluster #1 Of 1), Eukaryotic | Eukaryotes | 640 | 0.41 | Binding ≤ 10μM |
KC1D-1-E | Casein Kinase I Delta (cluster #1 Of 1), Eukaryotic | Eukaryotes | 170 | 0.45 | Binding ≤ 10μM |
LCK-1-E | Tyrosine-protein Kinase LCK (cluster #1 Of 4), Eukaryotic | Eukaryotes | 40 | 0.49 | Binding ≤ 10μM |
MK14-1-E | MAP Kinase P38 Alpha (cluster #1 Of 3), Eukaryotic | Eukaryotes | 2800 | 0.37 | Binding ≤ 10μM |
RIPK2-1-E | Serine/threonine-protein Kinase RIPK2 (cluster #1 Of 1), Eukaryotic | Eukaryotes | 26 | 0.51 | Binding ≤ 10μM |
SRC-1-E | Tyrosine-protein Kinase SRC (cluster #1 Of 3), Eukaryotic | Eukaryotes | 170 | 0.45 | Binding ≤ 10μM |
TIE2-1-E | Tyrosine-protein Kinase TIE-2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 7000 | 0.34 | Binding ≤ 10μM |
VGFR2-1-E | Vascular Endothelial Growth Factor Receptor 2 (cluster #1 Of 2), Eukaryotic | Eukaryotes | 1600 | 0.39 | Binding ≤ 10μM |
Z81072-1-O | Jurkat (Acute Leukemic T-cells) (cluster #1 Of 10), Other | Other | 400 | 0.43 | Functional ≤ 10μM |
Uniprot | Swissprot | Description | Affinity (nM) | LE (kcal/mol/atom) | Type |
---|---|---|---|---|---|
KC1D_HUMAN | P48730 | Casein Kinase I Delta, Human | 170 | 0.45 | Binding ≤ 1μM |
MK14_HUMAN | Q16539 | MAP Kinase P38 Alpha, Human | 1000 | 0.40 | Binding ≤ 1μM |
RIPK2_HUMAN | O43353 | Serine/threonine-protein Kinase RIPK2, Human | 26 | 0.51 | Binding ≤ 1μM |
CSK_HUMAN | P41240 | Tyrosine-protein Kinase CSK, Human | 640 | 0.41 | Binding ≤ 1μM |
LCK_MOUSE | P06240 | Tyrosine-protein Kinase LCK, Mouse | 40 | 0.49 | Binding ≤ 1μM |
LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 151 | 0.45 | Binding ≤ 1μM |
SRC_HUMAN | P12931 | Tyrosine-protein Kinase SRC, Human | 170 | 0.45 | Binding ≤ 1μM |
SRC_CHICK | P00523 | Tyrosine-protein Kinase SRC, Chick | 53 | 0.49 | Binding ≤ 1μM |
KC1D_HUMAN | P48730 | Casein Kinase I Delta, Human | 170 | 0.45 | Binding ≤ 10μM |
MK14_HUMAN | Q16539 | MAP Kinase P38 Alpha, Human | 1000 | 0.40 | Binding ≤ 10μM |
RIPK2_HUMAN | O43353 | Serine/threonine-protein Kinase RIPK2, Human | 26 | 0.51 | Binding ≤ 10μM |
CSK_HUMAN | P41240 | Tyrosine-protein Kinase CSK, Human | 640 | 0.41 | Binding ≤ 10μM |
LCK_MOUSE | P06240 | Tyrosine-protein Kinase LCK, Mouse | 40 | 0.49 | Binding ≤ 10μM |
LCK_HUMAN | P06239 | Tyrosine-protein Kinase LCK, Human | 151 | 0.45 | Binding ≤ 10μM |
SRC_HUMAN | P12931 | Tyrosine-protein Kinase SRC, Human | 170 | 0.45 | Binding ≤ 10μM |
SRC_CHICK | P00523 | Tyrosine-protein Kinase SRC, Chick | 53 | 0.49 | Binding ≤ 10μM |
TIE2_HUMAN | Q02763 | Tyrosine-protein Kinase TIE-2, Human | 7000 | 0.34 | Binding ≤ 10μM |
VGFR2_HUMAN | P35968 | Vascular Endothelial Growth Factor Receptor 2, Human | 1600 | 0.39 | Binding ≤ 10μM |
Z81072 | Z81072 | Jurkat (Acute Leukemic T-cells) | 1200 | 0.39 | Functional ≤ 10μM |
Description | Species |
---|---|
activated TAK1 mediates p38 MAPK activation | |
Activation of PPARGC1A (PGC-1alpha) by phosphorylation | |
Activation of the AP-1 family of transcription factors | |
ADP signalling through P2Y purinoceptor 1 | |
c-src mediated regulation of Cx43 function and closure of gap junctions | |
CD28 co-stimulation | |
CD28 dependent PI3K/Akt signaling | |
CD28 dependent Vav1 pathway | |
CDO in myogenesis | |
Circadian Clock | |
Constitutive PI3K/AKT Signaling in Cancer | |
CTLA4 inhibitory signaling | |
DAP12 signaling | |
DCC mediated attractive signaling | |
Downstream signal transduction | |
Downstream TCR signaling | |
DSCAM interactions | |
EPH-ephrin mediated repulsion of cells | |
EPH-Ephrin signaling | |
EPHA-mediated growth cone collapse | |
EPHB-mediated forward signaling | |
Ephrin signaling | |
ERK/MAPK targets | |
GAB1 signalosome | |
Generation of second messenger molecules | |
GP1b-IX-V activation signalling | |
GPVI-mediated activation cascade | |
GRB2:SOS provides linkage to MAPK signaling for Integrins | |
Integrin alphaIIb beta3 signaling | |
Integrin cell surface interactions | |
Interleukin-1 signaling | |
Interleukin-2 signaling | |
JNK (c-Jun kinases) phosphorylation and activation mediated by activated human | |
KSRP destabilizes mRNA | |
Loss of Nlp from mitotic centrosomes | |
Loss of proteins required for interphase microtubule organization from the ce | |
NCAM signaling for neurite out-growth | |
Nef and signal transduction | |
Nef Mediated CD4 Down-regulation | |
Netrin mediated repulsion signals | |
Neurophilin interactions with VEGF and VEGFR | |
NOD1/2 Signaling Pathway | |
Oxidative Stress Induced Senescence | |
p130Cas linkage to MAPK signaling for integrins | |
p38MAPK events | |
p75NTR recruits signalling complexes | |
PD-1 signaling | |
PECAM1 interactions | |
Phosphorylation of CD3 and TCR zeta chains | |
PIP3 activates AKT signaling | |
Platelet sensitization by LDL | |
Recruitment of mitotic centrosome proteins and complexes | |
Regulation of KIT signaling | |
Regulation of PLK1 Activity at G2/M Transition | |
Signal regulatory protein (SIRP) family interactions | |
Signaling by EGFR | |
Signaling by ERBB2 | |
Signaling by SCF-KIT | |
TAK1 activates NFkB by phosphorylation and activation of IKKs complex | |
Thrombin signalling through proteinase activated receptors (PARs) | |
Tie2 Signaling | |
Translocation of ZAP-70 to Immunological synapse | |
VEGF binds to VEGFR leading to receptor dimerization | |
VEGFA-VEGFR2 Pathway | |
VEGFR2 mediated cell proliferation |
No pre-computed analogs available. Try a structural similarity search.